Healthcare provider profile · identity verified

Bernard J Bernacki, D.O

Family Practice · PITTSBURGH, PA · NPI 1831168699

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	210	67
Levothyroxine Sodium	Levothyroxine Sodium	193	58
Simvastatin	Simvastatin	156	51
Gabapentin	Gabapentin	144	34
Citalopram Hbr	Citalopram Hydrobromide	142	51
Amlodipine Besylate	Amlodipine Besylate	140	38
Omeprazole	Omeprazole	138	42
Metformin Hcl	Metformin Hcl	124	39
Azithromycin	Azithromycin	121	72
Atenolol	Atenolol	117	35
Montelukast Sodium	Montelukast Sodium	109	36
Prednisone	Prednisone	99	57
Losartan Potassium	Losartan Potassium	97	32
Lorazepam	Lorazepam	96	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	92	17
Tamsulosin Hcl	Tamsulosin Hcl	86	30
Pantoprazole Sodium	Pantoprazole Sodium	84	25
Eliquis	Apixaban	82	21
Sertraline Hcl	Sertraline Hcl	77	23
Lisinopril	Lisinopril	65	22
Furosemide	Furosemide	64	22
Metoprolol Tartrate	Metoprolol Tartrate	64	21
Tramadol Hcl	Tramadol Hcl	60	15
Trazodone Hcl	Trazodone Hcl	59	16
Fluoxetine Hcl	Fluoxetine Hcl	53	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	51	18
Mirtazapine	Mirtazapine	50	14
Allopurinol	Allopurinol	47	12
Paroxetine Hcl	Paroxetine Hcl	43	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	42	22
Albuterol Sulfate Hfa	Albuterol Sulfate	41	19
Metoprolol Succinate	Metoprolol Succinate	40	14
Ondansetron Hcl	Ondansetron Hcl	40	suppressed
Donepezil Hcl	Donepezil Hcl	39	suppressed
Famotidine	Famotidine	38	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	37	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	37	11
Potassium Chloride	Potassium Chloride	34	11
Carvedilol	Carvedilol	31	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	30	suppressed
Bupropion Hcl	Bupropion Hcl	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Alprazolam	Alprazolam	27	suppressed
Clonazepam	Clonazepam	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	26	suppressed
Trulicity	Dulaglutide	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	21	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Tradjenta	Linagliptin	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Rizatriptan	Rizatriptan Benzoate	19	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Glipizide	Glipizide	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Ezetimibe	Ezetimibe	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Cephalexin	Cephalexin	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Nateglinide	Nateglinide	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error